Carbon Monoxide Poisoning: Pathogenesis, Management, and Future Directions of Therapy (2017)

Peer-Reviewed Study · Rose JJ, Wang L, Xu Q, McTiernan CF, Shiva S, Tejero J, Gladwin MT · March 1, 2017

Rose JJ et al., 2017-03-01: Review of carbon monoxide poisoning pathogenesis and management describing the mitochondrial and inflammatory mechanisms of injury, stating that there is no antidotal therapy and that hyperbaric oxygen significantly reduces permanent effects.

The neurologic deficits do not necessarily correlate with blood CO levels but likely result from the pleiotropic effects of CO on cellular mitochondrial respiration, cellular energy utilization, inflammation, and free radical generation

Abstract

Rose JJ et al., 2017-03-01: Review of carbon monoxide poisoning pathogenesis and management describing the mitochondrial and inflammatory mechanisms of injury, stating that there is no antidotal therapy and that hyperbaric oxygen significantly reduces permanent effects. Narrative review, not a trial. PMID 27753502; DOI 10.1164/rccm.201606-1275CI. The review does not present methylene blue as a treatment for carbon monoxide poisoning; it supports the claim that hyperbaric oxygen's benefit is uncertain, not that methylene blue is superior. Study type: review.